Cerus Corporation
CERS US1570851014
Cerus Corp is a biomedical products company focused on the field of blood transfusion safety. The INTERCEPT Blood System is designed to reduce the risk of transfusion-transmitted infections by inactivating a broad range of pathogens such as viruses, bacteria, and parasites. The company sells its INTERCEPT platelet and plasma systems in the United States of America, Europe, the Commonwealth of Independent States countries, the Middle East, and selected countries in other regions around the world. The firm continues to operate in only one segment: Blood safety and generates revenue from the same.
Annual Performance 1
| 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|
| -2% | -48% | -42% | -29% | 7% |
Annual Insiders Turnover, USD 2
1 annual and historical performance metrics are recalculated on a daily basis;
2 represents the total value of insider transactions (both buying and selling);
Insider Activity
| Person | Price | Shares | Total | Published | Completed |
|---|---|---|---|---|---|
| Gregory Dean A. |
1.25 USD |
25,000 Bought |
31,250 USD |
25/08/2025 | 25/08/2025 |
| Jensen Chrystal CLO |
1.45 USD |
30,075 Sold |
43,609 USD |
13/03/2025 | 14/03/2025 |
| Benjamin Richard J CMO |
1.45 USD |
30,075 Sold |
43,609 USD |
13/03/2025 | 14/03/2025 |
| Jayaraman Vivek K COO |
1.45 USD |
46,004 Sold |
66,706 USD |
13/03/2025 | 14/03/2025 |
| Green Kevin Dennis CFO |
1.45 USD |
36,740 Sold |
53,273 USD |
13/03/2025 | 14/03/2025 |
| Greenman William Mariner CEO |
1.45 USD |
122,827 Sold |
178,099 USD |
13/03/2025 | 14/03/2025 |
| Jensen Chrystal CLO |
1.45 USD |
18,949 Sold |
27,476 USD |
13/03/2025 | 13/03/2025 |
| Benjamin Richard J CMO |
1.45 USD |
18,949 Sold |
27,476 USD |
13/03/2025 | 13/03/2025 |
| Greenman William Mariner CEO |
1.45 USD |
71,086 Sold |
103,075 USD |
13/03/2025 | 13/03/2025 |
| Jayaraman Vivek K COO |
1.45 USD |
29,985 Sold |
43,478 USD |
13/03/2025 | 13/03/2025 |